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To Fran,

ABSTRACT 
Infertility is an increasing medical and social problem affecting more than 10% of 
couples worldwide. Many underlying causes of human infertility have been overcome 
by assisted reproductive techniques; nevertheless, the implantation process remains one 
of the rate-limiting step as regards the success of the treatment. A prerequisite for 
successful implantation is the adequate preparation of a receptive endometrium and the 
establishment and maintenance of a viable embryo. The success of implantation further 
relies upon a two-way dialogue between the embryo and the endometrium. The 
molecular bases of these preimplantation and implantation processes in humans are not 
well known. 
The general aim of the current thesis was to add more understanding into the complex 
mechanism of human embryo implantation; to identify different factors that play role in 
endometrial and embryo preparation for successful implantation. 
 
In our first approach of identifying factors important for endometrial maturation to 
a receptive phase, we applied single gene analysis and genome expression analysis to 
fertile women and women with unexplained infertility. In the endometria of fertile 
women we identify previously known and new genes and pathways expressed in 
receptive endometrium, and that several of these genes and pathways were 
dysregulated in the endometria of women with no explainable reason for their fertility 
complications. These pathways included LIF pathway and JAK-STAT signalling 
cascade, coagulation cascade, inflammatory responses, lipid metabolism, and others. 
We also identified genetic variation in genes involved in blood coagulation to influence 
gene and protein expression levels in the endometrial cells, and their association with 
unexplained infertility was demonstrated. Further, we found pinopodes, the endometrial 
morphological markers, to be abundant in fertile endometria, but scarce in infertile 
endometria at the time of embryo implantation. 
Our second study approach was to analyse factors important for implantation-
competent blastocyst development. For that we analysed human embryos cultured in 
vitro. We found a major wave of transcriptional down-regulation in preimplantation 
embryos, where one possible down-regulation mechanism could operate via microRNA 
molecules. 
Finally, we aimed to identify interactions between receptive endometrium and 
blastocyst-stage embryo. For that we applied a novel network profiling algorithm 
HyperModules, which combines topological module identification and functional 
enrichment analysis. The main curated embryo-endometrium interaction network 
highlighted the importance of cell adhesion molecules in the implantation process. Also 
cytokine-cytokine receptor interactions were identified, where osteopontin, LIF and 
LEP pathways were intertwining. We also identified several novel players in human 
embryo-endometrium interactions at the time of implantation. 
 
The current thesis gives new insights into the processes involved in successful 
implantation in humans. Increasing our knowledge in the processes involved in 
preimplantation and implantation will facilitate the development of strategies to 
manipulate endometrial function, embryo development, and embryo-endometrium 
dialogue in order to promote successful implantation or to inhibit infertility. 
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1 INTRODUCTION 
More than 10 per cent of couples worldwide are involuntary childless due to infertility. 
Infertility is not only a medical problem, but has also often social and psychological 
implications. In Europe, low birth rate is one of the distinctive population features in 
most countries, and with delayed childbearing the need for infertility treatment is 
increasing. Although many underlying causes of human infertility have been overcome 
by assisted reproductive techniques, the implantation process remains rate-limiting step 
with regards to the success of treatment. A prerequisite for successful implantation is an 
adequate preparation of receptive endometrium and normally developed viable embryo. 
The success of implantation further relies upon a two-way communication between the 
embryo and the uterus. In order to increase success rates, there is, therefore, a 
continuing need to understand the molecular basis of the preimplantation and 
implantation processes. Many studies have been performed to improve our 
understanding of these mechanisms, but the majority of the knowledge regarding 
human embryo development and implantation is derived from animal models. Studies 
on human endometrium provide useful information on endometrial preparation for 
implantation. Nevertheless, there is still a lack of diagnostic and therapeutic tools for 
implantation dysfunction, and an optimal marker for defining a state of endometrial 
receptivity is needed.  
 
 
1.1 FERTILITY AND INFERTILITY 
 
Fertility is the natural capability to give life. Fertility can be measured by the time taken 
to achieve pregnancy. Time-to-pregnancy is expressed in monthly fecundity rate, which 
in humans, compared to other mammalian species, is relatively low ~20% (Evers, 
2002). It has been estimated that 79% of the population is fertile, 18% subfertile or 
infertile and 3% superfertile (Evers, 2002). In addition to subfertility, the incidence of 
embryo wastage and pregnancy loss is relatively high in humans, estimated to be 30% 
prior to implantation, a further 30% of early pregnancy loss, and over 10% of clinical 
pregnancies (Blohm, et al., 2008; Macklon, et al., 2002). 
 
In humans, the prevalence of infertility is high, affecting over 10% of couples of fertile 
age (Boivin, et al., 2007). Infertility is defined as inability of a couple to become 
pregnant within a year without using any contraceptives (Workshop, 2002). It is 
estimated that over 72 million women worldwide, aged 20 – 44, are currently infertile, 
however, only every second couple seeks for infertility medical care (Boivin, et al., 
2007). The reason of infertility in a couple could be caused by female (over one-third) 
or by male factor (over one-third) or by a combination of problems in both partners, or 
is unexplained (approximately 20%) (1996). Female fertility is regulated by a complex 
coordination and synchronization of interactions in the hypothalamic-pituitary-ovarian 
axis. Female fertility can thus be influenced by different diseases or dysfunctions of 
reproductive tract, neuroendocrine system, and immune system or by any general 
disease. Major causes of female infertility are disorders in ovulation (most commonly 
polycystic ovary syndrome, PCOS), tubal factor infertility, endometriosis and 
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unexplained infertility (Smith, et al., 2003). The most prevalent causes of female 
infertility according to the diagnostic and treatment guidelines by The ESHRE Capri 
Workshop (1996; Workshop, 2002) are summarised in Table 1. In a case of male factor 
infertility, it is generally defined by the finding of an abnormal semen analysis (WHO, 
1999). 
 
Table 1. Aetiology of female infertility. 
Anovulatory infertility 
  Premature ovarian failure (POF) and early menopause 
  Polycystic ovary syndrome (PCOS) 
Tubo-peritoneal infertility 
  Tubal factor infertility 
  Endometriosis 
Autoimmunity 
  POF 
  Recurrent pregnancy loss 
  Autoimmunity associated with infertility 
Uterine abnormalities 
  Malformations 
  Myomas 
Unexplained infertility 
 
 
 
1.2 UNEXPLAINED INFERTILITY 
 
Unexplained infertility is one of the most common diagnoses in a fertility clinic 
(Adamson and Baker, 2003; Brandes, et al., 2010; Hull, et al., 1985). The estimated 
incidence of the diagnosis ranges in different studies from 15% (Guzick, et al., 1994) to 
30% (Smith, et al., 2003; Templeton and Penney, 1982). The classification as 
unexplained infertility is applied to an infertile couple whose standard investigations 
include semen analysis, tests of ovulation and tubal patency have failed to detect any 
gross abnormalities (Crosignani, et al., 1993). Its aetiology seems heterogeneous, with 
suggested potential causes ranging from disturbances in endocrinology, immunology, 
genetics and reproductive physiology (Pellicer, et al., 1998). Unexplained infertility 
could arise from a defect in fertility that cannot be detected by the routine infertility 
evaluation, or it could represent the lower extreme of normal distribution of fertility, 
70% of these couples achieve pregnancy in 2 years, while 20 – 30% remain infertile 
even after 9 years (Barnea, et al., 1985; Templeton and Penney, 1982). 
 
Women in couples with infertility of unknown cause have normal ovulatory cycles and 
hormonal profiles, no organ pathology, and their partners show no evidence of semen 
quality problems. However, in some cases, these women might be misdiagnosed as 
unexplained infertile, as thorough evaluation for pelvic pathologies with laparoscopy is 
not a standard approach in all clinics (Moayeri, et al., 2009). With further evaluation, 
women misdiagnosed as unexplained infertile may suffer from endometriosis, tubal 
infertility, premature ovarian aging or immunological infertility (Gleicher and Barad, 
2006). It is estimated that older women are more likely to be diagnosed with 
unexplained infertility, this is due to the negative effect of age on the ovarian reserve 
(Gleicher and Barad, 2006; Maheshwari, et al., 2008).  
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Nevertheless, one reason for fertility problems in these women could be abnormalities 
in endometrial receptivity. Embryos cannot implant in the uterus with defects in the 
endometrium. Several microarray studies have revealed dysregulation of genes in 
endometria of women with fertility complications, which may influence endometrial 
competence (Aghajanova, et al., 2010; Burney, et al., 2007; Horcajadas, et al., 2008; 
Koler, et al., 2009; Qiao, et al., 2008; Tapia, et al., 2008a). So far, assessment of the 
endometrium beyond its appearance on ultrasound examination is limited due to lack of 
clinically useful tests of receptivity. The development of novel tests of endometrial 
function are likely to reduce the proportion of couples with no clear cause of their 
infertility, as the contribution of aberrant endometrial maturation becomes clear 
(Stavreus-Evers, et al., 2011). 
 
 
1.3 HUMAN ENDOMETRIUM 
 
The endometrium is regarded as an endocrine organ, producing several hormones, 
growth factors and cytokines. The main function of the endometrium is to allow a 
timely implantation of a viable embryo, and to provide a nurturing local environment 
that supports establishment of a successful pregnancy. Endometrial functions include 
the ability to trigger its own destruction in the absence of pregnancy, and protection 
against invading pathogens (Johnson and Everitt, 2000). 
 
The endometrium consists of a basal and a functional layer (Figure 1). The basal layer, 
adjacent to the myometrium, remains after menstruation and undergoes only limited 
changes during the menstrual cycle (Aplin, et al., 2008). This is the layer from which 
the endometrium regenerates after menstrual shedding. The other layer, the functional 
layer, is highly sensitive and responsive to oestrogen, progesterone and androgens and 
is subsequently discharged during menstruation (Tabibzadeh, 1998). This layer has a 
cycle of proliferation, secretion and degeneration. The purpose of the functional layer is 
to prepare the endometrium for embryo implantation. 
 
The endometrium can be divided into two hormone responding tissue types: a single 
layer of columnar epithelium, and stromal connective tissue, that contains fibroblasts, 
endothelial cells and leukocytes (Aplin, et al., 2008). The types of epithelium in the 
endometrium are luminal epithelium (covers the endometrial surface) and glandular 
epithelium (lining of glands). Luminal epithelium provides the sites of implantation, as 
it is the first maternal surface for the trophoblast cells of the implanting embryo to 
encounter (Meseguer, et al., 2001). In addition, luminal epithelium acts as a blood-
uterine lumen barrier, which prevents substances to enter the uterus from the blood 
(McRae and Kennedy, 1983). Glandular epithelial cells secrete several autocrine and 
paracrine factors required for endometrial maturation and embryo implantation. 
Fibroplasts are the dominant cell type of the stroma, and produce extracellular matrix, 
metalloproteinases (MMPs), and other proteins (Aplin, et al., 2008). Stromal 
endothelial cells locate in the wall of arteries and veins, and are essential for the 
formation of new vessels from the existing ones, i.e. angiogenesis. Leukocytes are part 
of the immune system, mediating inflammatory response. They vary in number and 
type throughout the menstrual cycle (Critchley, et al., 1999; Salamonsen and Lathbury, 
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2000) and include T and B cells, mast cells, natural killer cells (uNK), macrophages, 
and neutrophils (Jabbour, et al., 2006). 
 
 
 
 
Figure 1. Simplified schematic figure of human endometrium. 
 
 
 
1.4 HORMONAL REGULATION OF ENDOMETRIAL CYCLE 
 
The menstrual cycle consists of a follicular phase (menstruation and proliferative 
phase) and a luteal (or secretory) phase, separated by ovulation (Figure 2). A normal 
cycle has approximately the same length in each time, from 25 to 35 days with an 
average of 28 days. The series of classic morphological changes in the endometrium 
occur in response to cyclical ovarian activity (Noyes, et al., 1975). 
 
Ovarian function is under the control of luteinising hormone (LH) and follicle 
stimulating hormone (FSH), which bind to their receptors in the ovary and regulate its 
function by promoting sex steroid production and folliculogenesis (Hillier, et al., 1994). 
The hypothalamus secretes pulses of GnRH, which regulates the pituitary gland to 
produce gonadotrophins in a similar pulsatile pattern. When gonadotrophins act on the 
follicles, the production of oestrogens increases and reaches its maximal level in the 
preovulatory follicle. Estradiol is the main oestrogen synthesised and has dual action in 
gonadotrophin secretion – at low circulating levels it exerts negative feedback control 
over FSH and LH production by inhibiting GnRH secretion, meanwhile at high 
circulating levels positive feedback becomes a dominant force and LH and FSH surge 
is induced, followed by the ovulation. Ovarian follicular phase coincides with the 
endometrial proliferative phase (Figure 2). Growing levels of estradiol exert mitogenic 
effects on the endometrium, leading to cell division and growth of the endometrium 
and angiogenesis (Aplin, et al., 2008). 
 
 
  5 
 
 
Figure 2. The menstrual cycle. Cycle days, basal body temperature, hormone levels, 
ovarian cycle and uterine cycle are indicated (www.wikipedia.org)*. 
 
 
 
After ovulation, the oocyte moves along the Fallopian tube for potential fertilization 
and the dominant post-ovulatory follicle transforms into corpus luteum. LH promotes 
luteinisation of mature follicles and maintains progesterone production from the corpus 
luteum. High levels of progesterone, in the presence of oestrogen, form a negative 
feedback action that suppresses gonadotrophin secretion. This coincides with the start 
of the endometrial secretory phase (Figure 2). Progesterone is the main hormone that 
regulates the endometrial maturation for blastocyst implantation. The progesterone-
dominated latter half of the menstrual cycle is constituted by an early, mid-, and late 
secretory phase. Implantation takes place during the mid-secretory phase. The pattern 
of sex steroid receptor expression in the secretory endometrium reflects the fact that the 
early secretory phase is regulated by both oestrogen and progesterone; the mid-
secretory phase is regulated by progesterone alone; and the late secretory phase is 
associated with progesterone withdrawal and, consequently, menstruation (Snijders, et 
al., 1992). The histological features characteristic for the receptive endometrium are 
increased glandular volume, secretion, edema, coiling of spiral arteries and 
decidualisation of the stroma (Jabbour, et al., 2006). In the absence of pregnancy, the 
corpus luteum degenerates, resulting in decrease of circulating steroids, that lead to 
enhanced secretion of FSH and the initiation of a new cycle (Speroff and Fritz, 2005). 
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1.5 ENDOMETRIAL RECEPTIVITY 
 
Endometrial receptivity refers to the time when luminal epithelium is favourable for 
blastocyst implantation. This limited time period, called also as implantation window, 
is restricted to approximately days 19 to 24 of a menstrual cycle of 28 days (Harper, 
1992; Lopata, 1996). This corresponds to the time when the embryo hatches, day 6 
after the LH surge, and it is subsequently ready for implantation within the following 
24 hours (Aplin, et al., 2008). 
 
The development of a receptive endometrium depends on adequate secretory 
transformation of the oestrogen-primed endometrium in response to progesterone. 
Significant developmental changes occur in luminal epithelium, glandular epithelium 
as well as in endometrial stroma. Many molecules have been identified in the 
involvement of this process, such as integrins and their ligands (e.g. osteopontin), 
mucins, growth factors (HB-EGF), cytokines (LIF, leptin, IL-1, IL-11), homeobox 
transcription factors (HOXA gene products), lipids and other molecules (Aghajanova, 
et al., 2008b; Giudice, 1999; Stavreus-Evers, et al., 2011; Wang and Dey, 2006).  
The availability of new methods for investigating human endometrium has provided 
deeper knowledge in the molecular regulation of endometrial receptivity. Gene 
expression microarrays allow studies on the expression levels of thousands of genes 
simultaneously. In recent years, the global gene expression analysis has been 
successfully applied in several endometrium transcriptome studies and distinct 
regulation of hundred of genes in different menstrual cycle phases has been 
demonstrated (Borthwick, et al., 2003; Carson, et al., 2002; Feroze-Zaidi, et al., 2007; 
Haouzi, et al., 2009a; Haouzi, et al., 2009b; Horcajadas, et al., 2004; Kao, et al., 2002; 
Mirkin, et al., 2005; Riesewijk, et al., 2003; Talbi, et al., 2006). Although each study 
has revealed many candidate genes for endometrial receptivity, the number of common 
genes distinguished is relatively limited (Horcajadas, et al., 2007).  
 
Opening of the implantation window is characterised by remarkable ultrastructural 
changes in endometrial epithelial cell morphology (Nikas, 1999). In several studies the 
time-point of implantation is coincided with the presence of endometrial pinopodes 
(Martel, et al., 1991). Pinopodes are cytoplasmic protrusions of the endometrial surface, 
arising from the apical surface of the epithelial cells and extending into the uterine 
cavity. Although some groups have questioned the correlation between pinopodes and 
endometrial receptivity (Quinn and Casper, 2009), the timed correlation of pinopode 
expression, period of blastocyst hatching, and preference of human blastocyst to attach 
to pinopodes suggest pinopodes as structural markers of receptive endometrium 
(Achache and Revel, 2006; Aghajanova, et al., 2008a; Bentin-Ley, et al., 1999). 
Furthermore, pinopode formation and maintenance is shown to be hormone dependent, 
where progesterone is crucial for their appearance, and oestrogen interferes with the 
formation or induces regression (Martel, et al., 1991; Stavreus-Evers, et al., 2001). 
Further, the co-expression of pinopodes and other markers of endometrial receptivity 
has been demonstrated, such as with integrin αvβ3 (Nardo, et al., 2003b), osteopontin 
(Lessey, 2003), glycodelin (Stavreus-Evers, et al., 2006), progesterone receptors 
(Stavreus-Evers, et al., 2001).  
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The relative lack of clinical investigation of the endometrium is partly from the lack of 
objective tools for examining endometrial receptivity in a clinical setting. As a result, 
most current therapeutic interventions aimed to modulate endometrial receptivity are 
empirical, with little evidence base to support their use (Stavreus-Evers, et al., 2011). 
Nevertheless, recent developments in understanding the molecular regulation of 
endometrial receptivity are offering novel insights into the role of the endometrium in 
determining whether or not implantation could be successful. Indeed, studies 
comparing endometrium at the pre-receptive and receptive phases in fertile women and 
women with poor reproductive success demonstrate that implantation failure is, at least 
in part, due to a failure of the endometrium to differentiate into a receptive state 
(Sharkey and Smith, 2003). 
 
 
1.5.1 LIF signalling pathway 
 
Numerous paracrine factors, mainly cytokines and growth factors are involved in the 
regulation of the endometrium towards the receptive phase. Leukaemia inhibitory 
factor (LIF) is the most intensively studied factor regarding uterine receptivity. LIF is a 
pleiotropic cytokine, which crucial role in successful implantation was established in 
mice (Stewart, et al., 1992). Animals lacking LIF gene produced normal blastocysts 
failed to implant in the LIF-deficient uterus, but were capable of implanting in a wild-
type uterus (Stewart, et al., 1992). Administration of LIF in LIF-deficient animals 
restored implantation in these mice (Chen, et al., 2000; Stewart, et al., 1992). There is 
evidence that LIF is involved in implantation in several other species, such as rhesus 
monkey and sheep (Vogiagis, et al., 1997; Yue, et al., 2000). However, the importance 
of LIF in human implantation is still unclear.  
 
LIF involvement in human endometrial receptivity has been studied by several groups 
(reviewed by Aghajanova et al. (Aghajanova, 2010)). LIF is expressed in the human 
endometrium in a menstrual cycle-dependent manner, maximal LIF secretion coincides 
with the window of implantation (Arici, et al., 1995; Chen, et al., 1995). Although LIF 
expression is an indicator of receptive endometrium, its role in the assessment of 
implantation potential in humans is controversial (Aghajanova, 2010), and use of 
recombinant human LIF has failed to improve the implantation and pregnancy 
outcomes after assisted reproductive techniques in women with recurrent implantation 
failure (Brinsden, et al., 2009). 
 
LIF acts through binding to its receptor LIFR, which forms a heterodimer with a 
specific subunit common to all members of that family, the gp130 signal transducing 
subunit. This leads to activation of the JAK-STAT (Janus kinase-signal transcuder and 
activator of transcription), MAPK (mitogen activated protein kinase) or P13/AKT 
(phosphatidylinositol-3-kinase/Akt) pathways (Figure 3) (Carino, et al., 2008; Cheng, 
et al., 2001; Heinrich, et al., 2003). LIF signalling in the uterus occurs mainly through 
the JAK-STAT pathway (Cheng, et al., 2001). Activation of JAKs causes 
phosphorylation of a family of transcription factors STATs (signal transducers and 
activators of transcription) (Schindler and Darnell, 1995). Negative regulation of the 
LIF pathway is exerted via the suppressors of cytokine signalling (SOCS), which 
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negatively regulates JAK-STAT signalling cascade by interacting with JAKs (Paiva, et 
al., 2009). 
 
LIFR and gp130 (IL6ST) knock-out mice, contrary to LIF-deficient mice, are fertile and 
do not have implantation problems, indicating that LIF can act through an alternative 
pathway (Dani, et al., 1998). Nevertheless, LIFR-deficient mice display different 
abnormalities, which culminate in early perinatal lethality (Ware, et al., 1995), and 
gp130 knock-out mice have impaired heart development and die before birth (Yoshida, 
et al., 1996). Human preimplantation embryos express LIF and both of its receptors 
(Wanggren, et al., 2007). Gp130 is present in human luminal and glandular epithelium 
throughout the menstrual cycle (Cullinan, et al., 1996). This suggests that LIF 
signalling pathway is necessary for a cross-talk with the implanting embryo, mediating 
paracrine signals to embryonic tissue and autocrine/paracrine signals in the endometrial 
tissue (Aghajanova, 2010). Indeed, it has been shown that LIF plays a role in both 
adhesive and invasive phases of human embryo implantation due to its anchoring effect 
on trophoblast and regulation of trophoblast differentiation (Dimitriadis, et al., 2010; 
Tapia, et al., 2008b).  
 
 
 
Figure 3. Leukaemia inhibitory factor (LIF) signalling pathway. LIF receptors LIFR 
(leukaemia inhibitory factor receptor) and gp130 (glycoprotein 130), JAK-STAT (janus 
kinase/signal transducer and activator of transcription) and MAPK (mitogen-activated 
protein kinase) cascades, and LIF signalling pathway inhibitor SOCS1 (suppressor of 
cytokine signalling 1) are indicated (Aghajanova, 2010). Published with permission from 
Wolters Kluwer Health. 
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1.5.2 Vascular regulation 
 
Angiogenesis is an essential component of endometrial regeneration and maturation. It 
is a process involving growth of new blood vessels from pre-existing vessels. 
Angiogenesis occurs periodically at three distinct stages in human endometrium: during 
menstruation for repair of the vascular bed; at the proliferative phase during rapid 
endometrial growth; and during secretory stage when spiral arterioles exhibit growth 
and coiling (Gargett, et al., 1999). Additionally, vascular development is important 
during implantation and early placentation (Torry, et al., 2007). At the time of 
implantation, adequate uterine vascularity is needed to provide a richly vascularised 
endometrium, and following the implantation, development and expansion of placental 
villous vasculature is needed to facilitate transport of nutrients and oxygen to the 
embryo (Torry, et al., 2007). It has been demonstrated in mice that inhibition of 
angiogenesis either before, or shortly after implantation interrupts placentation and 
results in resorption of all embryos (Klauber, et al., 1997), thus highlighting the critical 
role of angiogenesis in normal implantation and placentation. Further, derangements in 
endometrial haemostasis are believed to represent a potential source of implantation 
failure and subsequent pregnancy complications in humans (Azem, et al., 2004; 
Coulam, et al., 2006; Lockwood, et al., 1994). During the mid-secretory phase, when 
endometrial stromal cells decidualise around blood vessels, these cells are temporally 
and spatially positioned to create a local haemostatic milieu. This can counteract the 
threat of haemorrhage during the implantation process, as blastocyst-derived 
trophoblasts penetrate the spiral arteries to establish the primordial utero-placental 
circulation (Lockwood, et al., 1999). 
 
A wide range of soluble factors, some with well established angiogenic functions (e.g. 
VEGF, PIGF, FGF, TGFβ) (Torry, et al., 2007) as well as other factors, can contribute 
to vascular development and maintenance at the maternal-foetal interface. 
Hyaluronan-binding protein 2 (HABP2), also known as factor VII-activating 
protease (FSAP), is an extracellular serine protease, which has been shown to inhibit 
angiogenesis (Jeon, et al., 2006). HABP2 has also been shown to promote the 
coagulation cascade by acting as an activator of factor VII, independently of tissue 
factor, and in the fibrinolytic pathway activating pro-urokinase (Roemisch, et al., 2002; 
Romisch, et al., 1999) (Figure 4). Moreover, HABP2 seems to be involved in additional 
vascular regulation, since it has been shown to regulate migration of vascular smooth 
muscle cells (Kannemeier, et al., 2004), and vascular integrity (Mambetsariev, et al., 
2010). In the endometrium, HABP2 expression was significantly lower in subfertile 
women (Horcajadas, et al., 2005; Riesewijk, et al., 2003) and in women with inert 
intrauterine device (Horcajadas, et al., 2006).  
 
Tissue factor (TF), also known as coagulation factor III (F3), is the key initiator of the 
blood coagulation cascade. TF initiates haemostasis through binding to factor VII, 
while tissue factor pathway inhibitor (TFPI) inhibits the cascade (Figure 4). TF has 
been proposed to have a central role in the connection of haemostatic, angiogenic, and 
pro-inflammatory pathways (Krikun, et al., 2009), as TF acts as a signalling molecule 
that binds FVIIa and cleaves protease-activated receptor 2 (PAR-2), which plays a role 
in angiogenesis, inflammation, and tumor progression (Chen, et al., 2006; Chen and 
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Hogg, 2006; Wolberg, et al., 1999). Knock-down of TF gene resulted in embryo 
lethality in mice (Toomey, et al., 1996), while in the presence of low levels of TF, the 
TF-null embryos were rescued (Parry, et al., 1998). Endometrial TF is explicitly up-
regulated at the time of implantation, and any alteration in the expression can lead to 
various pathologies of the endometrium including infertility (Kato, et al., 2005; Krikun, 
et al., 2009). 
 
 
 
Figure 4. Simplified schematic illustration of coagulation cascade and related 
signalling, where factors tissue factor (TF), tissue factor inhibitor (TFPI), hyaluronan-
binding protein 2 (HABP2, also known as factor VII-activating protease) are indicated. 
Central proteins factors VII, X and V and their activated forms (a) are also shown. 
APC – activated protein C. ‘+’ indicates activators and ‘–’ refers to inhibitor. 
 
 
 
1.6 PREIMPLANTATION EMBRYO DEVELOPMENT 
 
After fertilisation, the human preimplantation embryo develops during the transport 
through the Fallopian tube into the uterus, a journey taking four days. The Fallopian 
tube provides space and biological environment for fertilisation of the oocyte, which is 
then actively transported by cilia and muscle contractions towards the endometrium 
(Croxatto, 2002).   
The embryo undergoes several changes including cleavage, embryonic genome 
activation, compaction, and cavitation during its development to form a blastocyst 
(Figure 5). At the 4-cell stage, the transcription starts to change from maternal to 
embryonic genome activation, and the maternal mRNAs are gradually degraded 
(Duranthon, et al., 2008). Maternal to embryonic gene activation shows two principal 
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transient waves of de novo transcription, where the first wave peaks between the 2- and 
4-cell stages and the second wave peaks at the 8-cell stage and precedes morula-to-
blastocyst formation, as shown in mice (Bell, et al., 2008; Hamatani, et al., 2004).  
 
 
Figure 5. Human embryo development (www.wikipedia.org)*. 
 
 
 
Within 24 hours after fertilisation, the zygote undergoes a regulated series of mitotic 
cell divisions. The zygote will enter the blastomere stage, then becomes a morula (16 
cell-stage), which will undergo compaction where the trophoblast cells (outer cell-
layer) form a compact epithelial structure, connected by tight junctions and microvilli. 
Synchronically, the blastocyst cavity is created and a blastocyst is formed, which will 
hatch from the zona pellucida. The zona pellucida is a glycoprotein membrane 
surrounding the oocyte, which prevents the embryo from falling apart and prevents two 
genetically distinct conceptuses from sticking together. The blastocyst cells are 
totipotent, meaning that these cells have the ability to differentiate into any cell type in 
the developing embryo. Trophoblast cells play a crucial role in the implantation process 
and establishment of pregnancy, as they are the first cells to reach the maternal surface, 
invade and establish the embryo–maternal dialogue (Meseguer, et al., 2001). 
Trophoblasts produce a number of cytokines, growth factors and many other factors, 
including hCG, IGF-1, MMPs, TNFα, CDH1, and interleukins, which facilitate 
communication with the maternal tract and thereby promote implantation and ongoing 
embryo development through paracrine, juxtarine and/or autocrine actions (Chen, et al., 
2005; Merviel, et al., 2001). 
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When the endometrium reaches the receptive stage, it is able to respond to signals from 
the preimplantation embryo for implantation. The so-called crosstalk requires several 
different molecules secreted both in an autocrine and paracrine manner from both the 
trophoblast cells and the endometrium. The involved molecules include integrins, 
matrix-degrading enzymes and their inhibitors, a variety of growth factors and 
cytokines, and their receptors and modulator proteins (Giudice, 1999; Nardo, et al., 
2003a). Disturbances in this two-way dialogue are believed to represent a major reason 
why over 60% of all pregnancies are terminated at the end of the peri-implantation 
period (Herrler, et al., 2003; Macklon, et al., 2002; Wilcox, et al., 1999). 
 
 
1.7 IMPLANTATION 
 
Implantation spans from the moment of hatching of the blastocyst to the formation of a 
primitive placental circulation system, and is initiated by the contact between the 
blastocyst and the endometrium. Implantation is a dynamic process, which involves 
embryo apposition, adhesion to the endometrial epithelium and invasion into the stroma 
(Loke, et al., 1995). The 4 days old embryo arrives to uterine cavity at the stage of 
morula or early blastocyst and implantation is believed to take place 6-7 days after 
fertilisation (Figure 5) (Croxatto, 2002). In the apposition phase the embryonic 
trophectoderm comes closely apposed to the uterine luminal epithelium and a loose 
connection is established. During the adhesion step, the contact between blastocyst and 
endometrium is sufficiently increased to resist dissociation by flushing. There is an 
active communication between the blastocyst and the endometrium at this stage, 
conveyed by receptor-ligand-interactions (Aplin and Kimber, 2004). When adhesion is 
established, trophoblast cells differentiate into syncytiotrophoblasts on the outside and 
cytotrophoblast on the inside. Invasion starts with lytic activity of syncytiotrophoblast 
cells that weaken endometrial structures, thus enabling the penetration of the blastocyst. 
The function of the decidua is to control trophoblast invasion into the spiral arteries, to 
provide nutrition for the embryo, and to protect the embryo from maternal 
immunological response. During the subsequent invasion phase of implantation, 
blastocyst penetrates endometrial luminal epithelium and enters the endometrial stroma. 
The goal of embryo invasion is to reach the decidua and to ensure the contact with 
endometrial blood supply (Enders, et al., 1986). By day 9, the embryo is completely 
implanted in the endometrium. The role of the endometrium is now the opposite of that 
in the initial adhesion phase; it is to actively limit the invasive course of action by the 
embryo. The balance between trophoblast invasion and maternal restraint on invasion is 
a requirement for a procedure that must be beneficial for the embryo without being 
detrimental to the mother. 
 
Both, adequate preparation of receptive endometrium and the development of a viable 
embryo are essential for successful implantation. The limited window of implantation 
ensures coordinated embryonic and endometrial development, thus minimising the risk 
of late implantation of compromised embryos. Besides its receptive role in the 
implantation, the endometrium appears to have a ‘selective’ role (Teklenburg, et al., 
2010a). Recently it was demonstrated that decidualising endometrial stromal cells 
assess the quality of embryos that have breached the luminal epithelium, serving as 
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biosensors of embryo quality (Teklenburg, et al., 2010b). This introduces a novel 
functional window ‘the window of natural embryo selection’, which enables maternal 
recognition and elimination of compromised pregnancies, regardless of the embryonic 
karyotype (Teklenburg, et al., 2010a).  
 
The cellular events that define various stages of implantation are known, but the 
molecules and molecular genetic pathways that are crucial to this process (and how 
they interact) are not well understood. It is ethically and practically impossible to study 
human implantation process in vivo, and we lack an ideal model with which to study 
embryo implantation in humans. Animal models do provide important information to 
the process regulating implantation, but as the process varies across species (Carson, et 
al., 2000), the results cannot always be extrapolated to humans. In vitro co-culture 
systems allow to study the signalling between embryo and endometrium, however, the 
current systems are relatively crude representations of the dynamic in vivo situation 
(Teklenburg and Macklon, 2009).  
 
Previous studies on the implantation process in humans have focused exclusively on 
analysis of the endometrium or the embryo. As a novel step in identifying the genetic 
players in the early dialogue between implanting embryo and endometrium, a recent 
study compared global gene expression pattern between blastocyst cells and 
endometrial cells in women undergoing in vitro fertilisation (IVF) treatment (Haouzi, et 
al., 2011). They detected several cytokines (PDGFA, PGF, IGF2BP1, IGF2BP3) to be 
up-regulated in blastocyst trophectoderm cells, while some of the corresponding 
receptors (PDGFRA, KDR) were highly expressed in the endometrium. Also several 
adhesion molecules (MCAM, ALCAM, CEACAM1, PECAM1), extracellular matrix 
proteins (LAMA1, LAMC1, LAMA2, FBN1 and others), integrins (ITGAE, ITGB8, 
ITGAV, ITGA9 and ITGB1), lectins (COLEC12, LGALS1 and others), and 
proteoglycans (HAPLN1, HMMR, CD44 and SDC2) were identified in the embryo-
endometrium cross-talk (Haouzi, et al., 2011). Stable adhesion through integrins 
expressed in blastocyst and in the endometrium, their extracellular matrix ligands, and 
different adhesion molecules are required for implantation (Kimber and Spanswick, 
2000; Lessey and Castelbaum, 2002; Reddy and Mangale, 2003). The importance of 
integrins and cytokines in implantation has been acknowledged by several previous 
studies (Aghajanova, 2010; Aplin, 2006; Aplin and Kimber, 2004; van Mourik, et al., 
2009). The initial attachment of the blastocyst to the uterine wall also involves low-
affinity carbohydrate ligand-binding molecules, such as selectins and galectins (Bazer, 
et al., 2009). 
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2 AIMS OF THE STUDIES 
The general aim of the current thesis was to add more understanding into the complex 
mechanism of human embryo implantation; to identify different factors that play role in 
endometrial and embryo preparation for successful implantation. 
 
Accordingly, the studies had the following aims: 
 
1. To examine the expression of leukaemia inhibitory factor (LIF) pathway in the 
pathogenesis of unexplained infertility, by analysing LIF, its receptors LIFR 
and gp130, and its inhibitor SOCS1 in endometria from fertile women and 
infertile women with unexplained infertility. 
 
2. To study tissue factor (TF) and its inhibitors TFPI and TFPI2 in secretory 
endometrium from fertile women and from women with unexplained infertility 
in relation to endometrial receptivity. Additionally, the aim was to analyse 
common variation in the regulatory area of TF and TFPI genes in association to 
gene expression levels and unexplained female infertility. 
 
3. To compare the genetic variation in hyaluronan-binding protein gene (HABP2) 
together with the protein expression in the endometrium at the time of 
implantation between women with unexplained infertility and fertile controls. 
Additionally, to investigate the possible role of HABP2 in human endometrial 
function. 
 
4. To investigate the endometrial gene expression profile in women with 
unexplained infertility in comparison with fertile controls at the time of embryo 
implantation in order to find potential predictive markers of uterine receptivity 
and to identify the molecular mechanisms of infertility.  
 
5. To analyse molecule-molecule interactions between the embryo and the 
endometrium at the time of implantation. Also, to identify genes and pathways 
that are activated within the preimplanting embryo and in the receptive 
endometrium. 
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3 MATERIALS AND METHODS 
 
3.1 PARTICIPANTS 
 
The study group of healthy fertile women consisted of volunteers from Stockholm or 
Uppsala, Sweden (Studies I, II, III, V) and from Valencia, Spain (Study IV). All these 
women had regular checkups at the gynaecologist, and they had no fertility-related 
disease. Some women for DNA analysis were post-menopausal, but the majority of the 
women, including all women for endometrial biopsy analysis, were of fertile age.  
 
The study group of infertile women consisted of participants undergoing assisted 
reproduction in Stockholm or Uppsala (Studies I, II, III, IV). All the biopsies were 
obtained during a natural, non-stimulated cycle. Unexplained infertility was diagnosed 
by means of a standard set of tests that included hormonal analyses and at least 2 
analyses of semen from the partner. All women had normal hormone levels, normal 
ovarian function and normal mid-secretory endometrial thickness assessed by 
transvaginal ultrasound scan. All infertile women showed normal tubal passage as 
demonstrated by hysterosonosalpingography and no recognisable endometriosis 
according to symptoms and clinical examination in transvaginal ultrasonography or 
diagnostic laparoscopy. 
 
Both fertile and infertile women in the studies donated endometrial material and/or 
blood sample for research (Table 2). A diagnosed group of infertile women undergoing 
IVF treatment at Örebro or Uppsala donated pre-implantation embryos (day 3 and day 
5 after fertilisation). The donated embryos had been frozen for future infertility 
treatment, and when there was a wish for no further treatment, they were donated for 
research. 
 
 
Table 2. Number of women (n) who donated material for studies. 
  Article I Article II Article III Article IV Article V 
Endometrium P (F) 2    4 
 ES (F) 6 10    
 MS (F) 14 20 8 5 4 
 MS (Inf) 14 20 19 4  
 LS (F) 4 11    
Blood F  108 151   
 Inf  65 105   
Embryos Day 3     68 
 Day 5     60 
F – fertile women; Inf – women with unexplained infertility; P – proliferative phase; ES 
– early secretory, MS – mid-secretory, and LS – late secretory phases. 
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3.2 BIOPSY SAMPLES 
 
All women scheduled for endometrial biopsy sampling underwent transvaginal 
ultrasonographic examination prior to biopsy. Serum progesterone concentration was 
measured to ascertain ovulatory cycles and the day of the LH surge was determined. 
Endometrial biopsies were obtained from the anterior wall of the uterine cavity. None 
of the women had used hormonal contraceptives for at least 3 months prior to the study, 
or used any intrauterine device for at least 6 months prior to the study. The obtained 
biopsies were further prepared for analysis by scanning electron microscopy (SEM), 
immunohistochemistry, real-time polymerase chain reaction (PCR), and microarray 
analysis. Day 3 and day 5 embryos were stored as frozen until RNA extraction for 
microarray analysis. 
 
3.2.1 SEM 
SEM is a unique method to study the surface of unsectioned samples. SEM was used to 
study the endometrial surface ultrastructure, to detect the presence of pinopodes. 
Endometrial biopsies were fixed in a solution containing glutaraldehyde which does not 
denature proteins and is therefore good for preservation of ultrastructure. Samples were 
then washed, dehydrated and dried. The specimens were then mounted on a holder, 
coated with a thin layer of platinum to make the specimen conductive by creating a 
layer, from which the scanning electron impulse is generated. 
 
3.2.2 Immunohistochemistry 
Immunohistochemistry (IHC) was used to determine the presence and cellular 
distribution of different proteins studied, such as LIF, LIFR, gp130, SOCS1, TF, TFPI, 
TFPI2 and HABP2. Relative amounts of protein can be detected by this semi-
quantitative measurement, although the absolute amount cannot be determined. In 
general, IHC staining technique enables to visualise antigens in frozen and paraffin-
embedded tissues via the sequential application of a specific antibody to the antigen 
(primary antibody), a biotinylated antibody to the primary antibody (secondary 
antibody), an enzyme conjugate (tertiary component) and a chromogenic substrate. The 
enzymatic activation of the chromogen results in a visible reaction product at the 
antigen site. We run each sample twice or three times to confirm the reproducibility of 
the experiment. Two observers, unaware of the identity of the slides, evaluated the 
staining intensities of the samples. A scoring system was used to determine the 
intensity of staining. 
 
Western blot was used to verify the specificity of TF, TFPI and TFPI2 antibodies used 
for IHC analysis in Study II. Term human placenta was used for tissue sample, as the 
expression of these proteins in placenta has been shown before. Placenta tissue pieces 
were homogenised. The gel electrophoresis was applied for separating placental 
proteins by size. Thereafter the separated proteins in the gel were transferred to a 
membrane, and then incubated with the primary and secondary (fluorescent conjugated) 
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antibodies. Antibodies that specifically bind to the protein of interest were visualised 
using fluorescent signals. 
 
3.2.3 Total RNA isolation 
Endometrial tissue was immediately snap-frozen and stored in liquid nitrogen until 
further analysis. Also the cultured embryos were stored as frozen until RNA extraction. 
Total RNA was extracted from samples for gene expression analysis of a single genes 
or the whole gene expression pattern.  
The cells were homogenised and the total RNA was extracted using commercial kit or 
the ‘TRIzol method’. The quality of the purified RNA was measured by a 
spectrophotometer (Article I) or Agilent bioanalyser (Articles II, IV, V). 
 
3.2.3.1 Real-time PCR 
 
Synthesis of the complementary DNA from total RNA was performed using reverse 
transcriptase. SYBR Green was used to detect the amplification of single genes in 
interest, such as LIF, LIFR, gp130 and SOCS1 (Article I); TF, TFPI and TFPI2 (Article 
II); and MMP26, HABP2, HBA, S100A8, and IGFBPI (Article IV).  
SYBR Green is a fluorogenic dye that exhibits little fluorescence when in solution, but 
emits a strong fluorescent signal upon binding to double-stranded DNA. SYBR Green 
provides the simplest and most economical format for detection and quantification of 
PCR products in real-time reactions. The advantages of SYBR Green are that it is 
inexpensive, easy to use, and sensitive. The disadvantage is that SYBR Green binds to 
any double-stranded DNA in the reaction, including primer-dimers and other non-
specific reaction products. Nevertheless, for single PCR product reactions with well-
designed primers, SYBR Green can work extremely well, with spurious non-specific 
background only showing up in very late cycles. We used glyceraldehyde-3-phosphate 
dehydrogenase gene (GAPDH) as internal control in real-time PCR; quantitative gene 
expression data are normalised to the expression levels of the housekeeping gene. To 
quantify the results obtained by real-time PCR, standard curve method was used. In this 
method, a standard curve is first constructed from RNA of known concentration. This 
curve is then used as a reference standard for extrapolating quantitative information for 
mRNA targets of unknown concentrations. We used different PCR platforms, ABI 
7500 Fast Real-Time PCR System (Studies I, II) and LightCycler platform (Study IV). 
 
3.2.3.2 Microarray analysis 
 
Microarray analysis was performed to study gene expression profiles in human 
receptive endometrium vs. endometrium of infertile women (Article IV), human 
receptive vs. non-receptive endometrium (Article V), and day 5 vs. day 3 embryos 
(Article V). 
Microarray analysis was performed using the Whole Human Genome Oligo Microarray 
(Agilent Technologies) (Article IV) and Affymetrix HG-U133 Plus 2.0 (Affymetrix) 
platforms (Article V). Total RNA was processed (reverse transcribed, amplified, 
labelled and hybridised) according to the instructions by Agilent Technical Manual or 
Affymetrix two-cycle GeneChip Eukaryotic small sample target labelling assay. Initial 
array data analyses were performed by using the R-statistical software system. The 
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primary microarray data are available in the public database Gene Expression Omnibus 
(GEO) repository (GSE16532) (Article IV), and in ArrayExpress repository (E-MEXP-
3111) (Article V).    
 
 
Table 3. Summarising table of used methods. 
Method Article 
Immunohistochemistry (IHC) I, II, III 
Scanning electron microscopy (SEM) I, II, IV 
Real-time PCR I, II, IV 
Restriction fragment length polymorphism analysis (RFLP) II 
TaqMan SNP genotyping assay III 
Western blot II 
Microarray analysis IV, V 
Migration assay III 
Statistical analysis I, II, IV, III, V 
Mathematical modelling V 
 
 
 
3.3 BLOOD SAMPLES AND GENOTYPING 
 
Blood samples were collected for polymorphism analysis in TF, TFPI (Article II) and 
HABP2 genes (Article III). Genomic DNA was extracted from blood using QIAamp 
DNA Blood Maxi kit. We used different genotyping methods, restriction fragment 
length polymorphism (RFLP) and TaqMan. 
 
3.3.1 RFLP 
We analysed single nucleotide polymorphisms (SNPs) TF -603 A/G (rs1361600), TFPI 
-399 C/T (rs10153820) and TFPI -287 T/C (rs10931292) using RFLP method. RFLP 
refers to a variance between samples of homologous DNA molecules as a result of 
differing locations of restriction sites. In the RFLP analysis, DNA strand is digested 
with restriction enzyme and the obtained restriction fragments are separated according 
to their lengths by gel electrophoresis. We used Agilent DNA 1000 Kit system for 
restriction fragment analysis, where interconnected set of microchannels are used for 
separation of fragments based on their size as they are driven electrophoretically 
through the chip. This system provides high resolution of smaller fragments, is easy 
and fast to use, however, it is more expensive than simple gel-electrophoresis.     
  
3.3.2 TaqMan assay 
We analysed polymorphisms rs7080536, rs1157916 and rs2240879 in HABP2 gene 
using TaqMan assays. TaqMan chemistry allows detection of PCR products via the 
generation of fluorescent signal. TaqMan probes depend on the 5'- nuclease activity of 
the DNA polymerase used for PCR to hydrolyze an oligonucleotide that is hybridized 
to the target sequence. TaqMan probes are oligonucleotides that have a fluorescent 
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reporter dye attached to the 5' end and a quencher moiety coupled to the 3' end. These 
probes are designed to hybridize to an internal region of a PCR product. In the 
unhybridised state, the proximity of the fluor and the quench molecules prevents the 
detection of fluorescent signal from the probe. Well-designed TaqMan probes require 
very little optimization, however, TaqMan probes can be expensive to synthesize, with 
a separate probe needed for each mRNA target being analyzed. 
 
 
3.4 MIGRATION ASSAY 
We used migration assay in Boyden Chamber format for assessing the ability of human 
trophoblast and endometrial endothelial cells to migrate towards a chemoattractant, 
HABP2, in order to investigate the role of HABP2 in the implantation process. Boyden 
Chamber is a popular traditional tool in studying cell migration in vitro. This assay is 
ideal to study migration via a chemoattractant gradient. However, the Boyden Chamber 
assay format can only be used for quantitative and endpoint analysis. Figure 6 
illustrates the Boyden Chamber method. Cultured cells are placed in an upper chamber 
in serum-free media, where the bottom is a porous membrane (pore size is dependent 
on the cell type being studied). The membrane serves as a barrier to discriminate 
migratory cells from non-migratory cells. Serum or another chemoattractant is placed in 
the well below.  
 
 
 
 
Figure 6. Schematic illustration of Boyden Chamber migration assay. 
 
 
 
3.5 STATISTICAL ANALYSIS 
 
For statistical analyses different software was used – Statistical Package for Social 
Sciences statistical software (SPSS) (Articles I, II, III, IV) and the R2.3.1 A Language 
and Environment (Articles IV, V). Additionally, for further analysis of microarray data 
we used MeV software and for functional analyses of dysregulated genes Database for 
Annotation, Visualisation and Integrated Discovery (DAVID) and Ingenuity Pathway 
Analysis (IPA) (Article IV). Software g:Profiler, Multi Experiment Matrix web tool 
and GraphWeb tool were used for complex mathematical modelling of embryo-
endometrium interactions (Article V).  
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In general, data are presented as mean ± SD, unless otherwise indicated. Nominal 
variables were analysed by χ2 tests. Allele frequencies were calculated to investigate 
the deviation from Hardy-Weinberg equilibrium and also to calculate the odds ratios 
(ORs). All continuous variables were assessed for normal distribution and in a case of 
deviation, square root transformation was conducted. We assessed the differences in 
continuous data between study groups by using parametric tests. In the case of 
deviation from normal distribution and in the case of limited sample size, the non-
parametric tests were used. For all analyses, a p value < 0.05 was considered 
statistically significant. 
 
 
Table 4. Summary of the five studies presented in the current thesis. 
Study Subjects (n) Studied variables 
I Healthy fertile women (26) 
Women with unexplained infertility 
(14) 
Pinopode formation 
LIF, LIFR, gp130, SOCS1 mRNA 
and protein expression in 
endometrium 
II Healthy fertile women (140) 
Women with unexplained infertility 
(65) 
Pinopode formation 
TF, TFPI, TFPI2 mRNA and protein 
expression in endometrium 
TF -603 A/G 
TFPI -399 C/T 
TFPI -287 T/C 
III Healthy fertile women (158) 
Women with unexplained infertility 
(116) 
Primary endometrial endothelial cells 
Human trophoblast cells 
HABP2 protein expression in 
endometrium 
HABP2 Gly543Glu (Marburg I) 
HABP2 -70 A/G 
HABP2 G/A in promoter region 
Migration assay of endothelial cells 
and trophoblast cells with HABP2 
IV Healthy fertile women (5) 
Women with unexplained infertility (4) 
Endometrial genome expression 
Pinopode formation 
Real-time PCR of MMP26, HABP2, 
HBA, IGFBP1, S100A8 genes 
V Healthy fertile women (8) 
Human embryos (128) 
 
Gene expression profile of non-
receptive vs. receptive endometria 
Gene expression profile of day 3 vs. 
day 5 embryos 
Embryo-endometrium interaction 
networks 
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4 RESULTS 
4.1 FACTORS INFLUENCING ENDOMETRIAL RECEPTIVITY 
 
4.1.1 LIF pathway (Studies I and V) 
 
First we set up to assess the expression of LIF pathway – LIF, LIFR, gp130 and its 
inhibitor SOCS1, in the endometrium of fertile women throughout the menstrual cycle. 
The mRNA expression levels of LIF, LIFR, gp130 and SOCS1 did not differ 
significantly in different cycle phases. On protein expression level, gp130 was 
significantly intensely expressed in luminal and glandular epithelium during mid-
secretory phase, meanwhile SOCS1 demonstrated apical staining in epithelial cells, 
however, no significant difference was detected throughout the cycle. Furthermore, 
SOCS1 correlated negatively with LIFR expression in luminal epithelial cells (Figure 
7).  
 
 Fertile  Infertile           NC 
 
Figure 7. Immunostaining of LIF (A, B, C), LIFR (D, E, F), gp130 (G, H, I) and 
SOCS1 (J, K, L) in fertile and infertile endometrium at the time of embryo implantation. 
NC – negative control. 
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Immunostaining of LIF and LIFR in fertile endometrium has been assessed in our 
previous study, where the expression correlated positively with the pinopode 
appearance, being highest in the mid-secretory phase (Aghajanova, et al., 2003). Also 
in our next study (Article V), where we compared the global gene expression levels in 
non-receptive (proliferative phase) and receptive phase endometria of fertile women, 
we detected significant up-regulation of LIF and gp130 at the time of embryo 
implantation. 
The comparison of LIF pathway endometrial expression in fertile and infertile women 
revealed that unexplained infertility in some women might be explained by 
disturbances in the LIF pathway. In fertile mid-secretory endometrium high levels of 
LIFR and gp130 protein expression correlated with low SOCS1 expression, meanwhile 
the opposite expression pattern was detected in most women with unexplained 
infertility (Table 5, Figure 7).  
  
 
Table 5. Mid-secretory phase endometrial samples from fertile and infertile women 
showing strong immunostaining of LIF, LIFR, gp130 and SOCS1. LE – luminal 
epithelium, GE – glandular epithelium. 
Strong staining Fertile % (n) Infertile % (n) 
LIF LE 85% (12) 64% (9) 
LIF GE 100% (14) 78% (11) 
LIFR LE 100% (12) 28% (4) 
LIFR GE 100% (12) 35% (5) 
Gp130 apical staining LE 100% (11) 14% (2) 
Gp130 apical staining GE 81% (9) 0% (0) 
Gp130 cytoplasmic staining LE 91% (10) 35% (5) 
Gp130 cytoplasmic staining GE 45% (5) 28% (4) 
SOCS1 apical staining LE 100% (14) 78% (11) 
SOCS1 apical staining GE 85% (12) 85% (12) 
SOCS1 cytoplasmic staining LE 0% (0) 28% (4) 
SOCS1 cytoplasmic staining GE 0% (0) 93% (13) 
 
 
 
4.1.2 Tissue factor pathway (Study II) 
 
We assessed the expression of tissue factor and its inhibitors throughout the secretory 
phase endometrium of fertile women. We detected TF and TFPI protein to have similar 
expression pattern in luminal and glandular epithelium, being highest at the time of 
embryo implantation (Figure 8). In most samples no TFPI staining in the stroma was 
detected. TFPI2 protein was highly expressed throughout the secretory phase, and in 
stroma showed descending pattern. On mRNA level, the expression pattern was 
different; TFPI mRNA transcripts were gradually rising through the secretory phase. 
Differences in mRNA and protein expressions could arise from different sample 
preparation method, as for real-time PCR the whole tissue sample is homogenised, and 
the upper part of the functional layer forms only a part of it. Additionally, the 
differences could arise from further gene expression regulation (e.g. epigenetic 
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modification) and/or post-translational modification. We also cannot rule out the 
interindividual variance as fewer samples were used for real-time PCR than for IHC 
analysis.  
 
Figure 8. Immunostaining of TF, TFPI and TFPI2 in early (ES), mid- (MS) and late 
secretory (LS) endometrium in fertile women, and in women with unexplained infertility 
(Inf) in the mid-secretory phase.  
 
 
 
We then compared TF and its inhibitors’ expression patterns in fertile women and 
infertile women at the time of implantation, and detected significantly higher TF 
mRNA and TFPI protein expression in the luminal epithelium in endometria of infertile 
women (Figure 8). In line with the high TFPI expression, TFPI -287 T/C 
polymorphism associated with unexplained infertility – infertile women presented more 
frequently T allele, and T allele has been shown in previous studies to favour protein 
expression (Amini Nekoo and Iles, 2008; Skretting, et al., 2010). In TF gene, -603 A/G 
SNP associated with endometrial protein expression level, being highest in women with 
GG genotype (Figure 9). However, no association with unexplained female infertility 
was detected. 
 
Figure 9. TF -603 A/G genotypes and TF immunostaining in the endometrium of 
women with unexplained infertility during mid-secretory phase. LE – luminal 
epithelium, GE – glandular epithelium. *Statistically significant difference in TF 
immunostaining intensity between genotypes. 
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4.1.3 HABP2 (Studies III, IV, and V) 
 
In the study of global gene expression analysis in fertile endometrium at the time of 
implantation, we detected the presence of HABP2 gene (Article V). When compared 
the endometrial gene expression profiles at the implantation window between fertile 
and infertile women, significantly lower levels of HABP2 were detected in women with 
unexplained infertility (Article IV), which was also confirmed by real-time PCR 
(Figure 10).  
 
 
 
Figure 10. HABP2 gene expression in the endometrium of infertile women vs. fertile 
women detected by microarray analysis and real-time PCR. 
 
 
Next we set up to analyse the HABP2 protein expression and localisation in the mid-
secretory endometrium (Study III). HABP2 was predominantly expressed in stromal 
cells and in vessels in fertile endometrium. In infertile women, HABP2 expression was 
again significantly reduced (Figure 11). As genetic variation in HABP2 gene has been 
shown to influence the expression (Sedding, et al., 2006), we conducted polymorphism 
analysis in these fertile and infertile women. We analysed rs1157916 in the promoter 
area, rs2240879 in 5’UTR and rs7080536 (Gly534Glu) in exon 13 of HABP2 gene. 
Minor rs1157916 A and the major rs2240879 A alleles, together with AA genotypes 
were significantly less frequent in women with unexplained infertility, who 
demonstrated lower HABP2 mRNA and protein expression levels. 
 
 
Figure 11. Immunohistochemical staining of HABP2 in the endometria of a fertile 
woman and an infertile woman (Inf) at the time of implantation. Negative control (NC) 
is indicated. 
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In order to study HABP2 possible role in the endometrium at the time of implantation, 
we set up a migration assay to analyse trophoblasts and endometrial endothelial cells 
migration toward HABP2 protein (the chemoattractant). The mean numbers of 
endometrial endothelial cells migrating toward HABP2 were significantly increased 
when compared with the positive control of 10% foetal calf serum. No difference in 
migrating trophoblast cell numbers was detected. 
 
 
4.1.4 Pinopodes (Studies I, II and IV) 
 
In fertile women, no pinopodes were observed in early secretory endometrial samples, 
while in mid-secretory phase pinopodes were detected in the majority of samples 
(≥88%) and on some samples from late secretory phase (≤20%) (Figure 12).  
 
 
Figure 12. SEM micrographs of endometrium obtained form fertile women during 
secretory phase (ES – early, MS – mid- and LS – late secretory) and women with 
unexplained infertility at mid-secretory phase (Inf). 
 
 
The appearance of pinopodes during the time of implantation in the endometrial 
samples was higher when compared to the early and late phase samples. In the 
endometria of fertile women the presence of pinopodes correlated positively with LIFR 
expression in luminal epithelium, and TF expression in glandular epithelial cells and in 
stroma. In women with unexplained infertility, the presence of pinopodes was reduced, 
and the number of pinopodes was significantly lower (Table 6). 
 
 
Table 6. Presence of pinopodes on the endometrial surface in fertile and infertile 
women at the time of embryo implantation (mid-secretory phase). 
Study Group of women Total no. of 
samples 
Samples with 
pinopodes (%) 
Few pinopodes 
I Fertile 17 15 (88)  
 Infertile 14 8 (57) + 
II Fertile 16 15 (93.8)  
 Infertile 15 12 (80) + 
IV Infertile 4 3 (75) + 
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4.1.5 Global gene expression pattern (Studies III and V) 
 
We compared the genome expression pattern of receptive endometrium vs. non-
receptive endometrium in fertile women in order to identify genes and gene networks 
activated at the time of embryo implantation. We detected up-regulation of 920 genes 
and down-regulation of 1257 genes. The down-regulated gene list presented pregnancy-
specific functions, such as gland development, the progesterone-mediated oocyte 
maturation pathway, and a maternal process involved in pregnancy. The up-regulated 
gene list was characterised by response to external stimulus, positive regulation of the 
immune system, extracellular matrix-receptor interaction, acute inflammatory response, 
innate immune response and macrophage activation during immune response. 
Functional categories such as cell adhesion, integrin cell surface interactions, and 
regulation of cell proliferation indicate endometrial preparation for embryo 
implantation. 
We then studied protein-protein interaction networks within the receptive 
endometrium. The analysis applied was based on the assumption that significantly 
induced genes may establish permanent and transient protein-protein interactions to 
create protein complexes and initiate signal transduction. For that, up-regulated genes 
in receptive endometrium were mapped to the Human Protein Reference Database 
(HPRD). The mapping resulted in endometrial network of 264 genes and 324 
interactions, which was further clustered into 144 modules. Next we based on the 
assumption that interacting proteins with many shared interactions are biologically 
more relevant. Such assessment of functional importance identified 10 of the most 
significant biological process, cell components, molecular functions and pathways for 
endometrial networks (Figure 13). The identified functions and pathways included 
various immune and inflammatory responses, the JAK-STAT signalling pathway, cell-
cell adherens junctions, focal adhesion, complement and coagulation cascades, and 
others. 
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Figure 13. Functional enrichment analysis of endometrial interaction networks. Red 
denotes Gene Ontology (GO) biological process, brown GO cellular component, green 
KEGG pathway, marine GO molecular function, and blue indicates Reactome pathway.  
 
 
 
We also compared endometrial genome expression between fertile women and women 
with unexplained infertility at the time of embryo implantation, in order to find 
potential predictive markers of uterine receptivity and to identify molecular 
mechanisms of infertility. Our cluster analysis demonstrated clear distinction between 
fertile and infertile women based on the differentially regulated genes (Figure 14). We 
identified a total of 145 significantly up-regulated and 115 down-regulated genes in the 
endometria of infertile women vs. controls. Genes involved in immune responses, 
signal transduction, binding, transport, lipid metabolism and extracellular matrix 
components, among other functions, showed elevated expression levels among infertile 
women. 24% of the up-regulated genes were with unknown function, and 38% of 
down-regulated genes were without known function. Down-regulated genes included 
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genes encoding transmembrane receptors, transcription factors, proteins involved in 
lipid metabolism and transmembrane transport, and other genes. We detected several 
potential target molecules that were dysregulated in infertile women, such as mucins 
(MUC4, MUC5B), the mucin-associated peptide TFF3, insulin-like growth factor 
binding protein-I (IGFBPI), metalloproteinases (MMP8, MMP10, MMP26), cytokines 
and chemokines (SCGB3A1, FAM3D, FAM3B, CCR7, CXCL6, IL21, CMTM5), 
integrins (ITGA8, the integrin-binding protein COL16A1), immunomodulators, lipids, 
genes involved in Wnt signalling (WISP2, WNT3A, CXXC4, PRKCG), and others.    
 
 
Figure 14. Cluster analysis of dysregulated gene expression in the endometrium during 
the time of implantation in fertile women (C) and in women with unexplained infertility 
(P). 
 
 
Functional analysis of differentially regulated genes using DAVID database revealed that 
21.1% of the aberrantly expressed genes in infertile vs. fertile women were involved in 
localization and 18.8% of the genes were involved in transport. In addition, a significant 
proportion of the genes were involved in ion transport, defence responses, digestion, and 
metabolic processes of multicellular organisms. A significant number of dysregulated 
genes were located in extracellular regions, regions integral to the plasma membrane, and 
in the extracellular matrix. As regards molecular functions, many genes were involved in 
transporter activity, and especially transmembrane transporter activity. The biological 
pathway analysis using IPA revealed that aberrant endometrial gene expression in infertile 
women could influence pathways involved in leukocyte extravasation signalling, lipid 
metabolism, and detoxification. Analysis of molecular relationships between differentially 
expressed genes in infertile women showed a complex network where the majority of 
signals were mediated through mitogen-activated protein kinase (ERKs, P38MAPK, Jnk) 
complexes, where different genes such as those for beta adrenergic receptors (ADRBs), 
metalloproteinases, IGFBPI and others seem to play important roles (Figure 15). 
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Figure 15. A network of the molecular relationships between differentially expressed 
genes in infertile women. The intensity of the node colour indicated the degree of up- 
(red) or down- (green) regulation. A white node indicates a gene that is not part of our 
dataset, but is interacting in the network.  
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4.2 FACTORS IMPORTANT FOR IMPLANTATION-COMPETENT 
BLASTOCYST DEVELOPMENT (STUDY V) 
 
We analysed the genome expression in blastocyst (day 5 embryos) and compared the 
pattern with day 3 embryos, in order to identify genes and gene networks activated in 
implantation-competent embryos. 2812 genes were up-regulated and 2824 genes down-
regulated in blastocysts. The list of down-regulated genes comprised a large fraction of 
transcription factors, also GO categories such as sexual reproduction, brain 
development, and pattern specification process were identified. The up-regulated gene 
list was characterised by genes involved in metabolic processes, development, and 
localisation. On single gene level, E-cadherin, transforming growth factor beta-1 
(TGFB1), gp130, different cathepsins (CTSB, CTSH, CTSD, CTSZ, CTSL1, CTSE, 
CTSA), prostaglandins (PTGES2, PTGES, PTGR1, PTGER3), and pregnancy-
associated glycoproteins (PSG1, PSG2, PSG4, PSG7, PSG10) were present. 
 
Figure 16. Functional enrichment analysis of embryo interaction networks. Red 
denotes Gene Ontology (GO) biological process, brown GO cellular component, green 
KEGG pathway, marine GO molecular function, and blue indicates Reactome pathway.  
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Next we studied protein-protein interaction networks within the blastocyst. The 
analysis was carried out the same way as described earlier in the section 4.1.5, the focus 
being on the list of up-regulated genes in blastocyst. The analysis resulted in embryonic 
network of 1096 genes and 1956 interactions, which were clustered into 325 modules. 
The functional importance of the 10 most significant biological processes, cellular 
components, molecular functions and pathways for embryo networks are presented in 
Figure 16. The identified functions and pathways included transcription regulation, 
developmental processes, regulation of cellular metabolic processes, intracellular 
signalling pathways, protein binding, and pathways in cancer, focal adhesion and 
adherens junction. 
 
Further, we implemented a computational procedure for revealing possibly active 
microRNAs (miRNAs) and their likely targets, based on genomic locations of miRNA 
genes and their predicted target sites, using public databases. We assumed that miRNA 
genes located in the immediate vicinity of their host genes (e.g. a miRNA gene located 
on the opposite strand of a host gene) may be subject to transcription in concert with 
the host gene. First, we compiled lists of miRNA genes that were potentially expressed 
in embryonic tissues because their host genes were differentially up-regulated in the 
samples. We considered a miRNA to be active if a significantly over-represented 
number of its predicted target genes were down-regulated in embryos. We identified 
numerous examples of active miRNAs in embryos, including hsa-mir-9, hsa-mir-19a, 
hsa-mir-20a, hsa-mir-548b, and others (Figure 17). We found a considerable proportion 
of target genes inhibited by miRNA as transcriptional regulators according to GO 
analysis. 
 
 
Figure 17. miRNAs and the number of putative target genes identified among 
embryonic genes. Bar colour intensity represents statistical significance of target gene 
enrichment (p < 0.05). 
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4.3 INTERACTIONS BETWEEN RECEPTIVE ENDOMETRIUM AND 
BLASTOCYST-STAGE EMBRYO (STUDY V) 
 
In the last study we set out to describe the inter-tissue interface that is initiated during 
implantation. We constructed an embryo–endometrium interaction network that 
encompassed genes induced in both endometrial and embryonic tissues. We extracted 
known protein–protein interactions from the HPRD that spanned the two tissues, such 
that each interaction comprised one gene induced in the embryo and the other induced 
in the endometrium. The interactions in the embryo–endometrium interaction network 
were further filtered using GO cell component annotations. We focused on proteins 
known to be localised near the outer cell boundaries such as membranes and the 
extracellular matrix, and excluded proteins localised within the cell cytoplasm and 
organelles, and nucleus. Proteins with no cellular component annotations were included 
in the analysis. In total we identified 105 modules, where functional enrichment 
analysis revealed functions and pathways, such as cell adhesion, focal adhesion, cell–
cell junctions, tight junctions, integrin cell surface interactions, extracellular matrix 
structural constituents, and others. We then created a high-confidence variant of the 
embryo–endometrium interface by careful literature curation, which resulted in the 
high-confidence network comprising of 96 genes, 87 interactions and 22 connected 
network components (Figure 18). The largest curated network was built up of 35 
interacting molecules between the two tissues belonging to the protein families of 
collagens (COL1A1, COL4A1, COL4A2, COL4A5, COL4A6, COL7A1), integrins 
(ITGA1, ITGB8), laminins (LAMA1, LAMA2, LAMA5, LAMB3, LAMC1, LAMC2) 
and fibulins (FBLN1, FBLN2), together with other molecules involved in cell adhesion 
(CD36, CD44, HABP2, TGFB1, VCAN, VEGFA). The second largest interaction 
network, of 14 genes, represented proteins involved in cytokine–cytokine receptor 
interaction, where osteopontin (SPP1), apolipoprotein D (APOD), leptin (LEP) and LIF 
pathways intertwine. The third largest interaction network united 4 molecules that are 
involved in tight junctions, including TJP1, occludin (OCLN) and claudin 4 (CLDN4). 
The next network in size demonstrated a novel interaction network in the human 
implantation process, comprising the hormone gastrin (GAST), the metalloprotein 
ceruloplasmin (CP), membrane metallo-endopeptidase (MME), and endothelin 1 
(EDN1). Several additional novel interactors in the embryo–endometrium interface 
were detected in our study, including the molecules Dickkopf 1 (DKK1), kringle 
containing transmembrane protein 1 (KREMEN1) and carcinoembryonic antigen-
related cell adhesion molecule 1 (CEACAM1).  
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Figure 18. Embryo-endometrium interaction network from protein-protein interaction 
data and literature curation. Node colour represents tissue-specific differential gene 
expression; blue – expressed in embryo, red – expressed in endometrium, grey – 
expressed in both tissue. 
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5 DISCUSSION 
 
5.1 FACTORS INFLUENCING ENDOMETRIAL RECEPTIVITY 
 
Receptive endometrium is crucial for blastocyst attachment and implantation, process 
in which both structural and functional changes take place. Many molecules have been 
identified as being important for the endometrial preparation to a receptive state, such 
as integrins and their ligands, mucins, growth factors, cytokines, lipids and other 
molecules (Aghajanova, et al., 2008a; Aghajanova, et al., 2008b). In the current thesis, 
applying genome-wide expression analysis, we detect the expression of many genes in 
the normal receptive endometrium that have previously been identified in connection 
with uterine receptivity, including LIF, HABP2, IL15, PAEP, SPP1 and others. In 
addition, we identify several relevant gene networks in the adequate preparation of 
receptive endometrium, such as those connected with the JAK-STAT signalling 
pathway, complement and coagulation cascades, focal adhesion, adherens junctions 
and inflammatory responses with major localisation in extracellular regions. The next 
finding in the current thesis is that in women with otherwise no reason for their 
infertility, several of these molecules and pathways involved in endometrial receptivity 
were dysregulated, such as mucins, metalloproteinases, cytokines, chemokines, 
integrins, and pathways involved in inflammatory responses, lipid metabolism, and 
detoxification. 
 
Next, our approach of single gene analyses is in line with the results from genome 
expression studies. We analysed LIF pathway, the activator of the JAK-STAT 
signalling cascade, expression in the endometrium of fertile and infertile women. The 
main finding of this study is that LIF signalling pathway expression was impaired in 
women with unexplained infertility (Figure 20), indicating that the reason for their 
fertility complications could be explained by disturbances in the LIF pathway at the 
time of embryo implantation, that less efficient LIF action could lead to aberrant 
endometrial receptivity. 
 
Our study of single gene approach was focusing on the factors involved in the blood 
coagulation cascade, which besides to maintaining the haemostatic balance, is related 
to other signalling pathways such as angiogenesis, inflammatory signalling, and 
protective signalling. We show distinct expression pattern of tissue factor pathway in 
the fertile secretory endometrium, and the spatial and temporal TF and TFPI expression 
during the mid-secretory phase of the menstrual cycle reflect their involvement at the 
time of embryo implantation. We also demonstrate that alteration in this well-regulated 
process of coagulation, specifically elevated TFPI protein expression may contribute to 
female infertility through unbalancing haemostatic balance at the site of embryo 
implantation toward reduced coagulation. Indeed, bleeding during the first trimester has 
been associated with risk of miscarriage (Hasan, et al., 2009). 
 
HABP2 was the next factor in the coagulation pathway that we analysed in the 
endometria of fertile and infertile women. Interestingly, HABP2 gene expression was 
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detected in our both array studies, being up-regulated in the fertile endometrium at the 
time of implantation and being down-regulated in women with no clear reason for their 
fertility complications. In fact, HABP2 is one of the few genes that has been detected in 
several independent array studies, and it is proposed as one of the few endometrial 
receptivity markers (Horcajadas, et al., 2007). The function of HABP2 in endometrial 
receptivity is not established, therefore we analysed the possible role of this protein in 
the endometrium at the time of implantation. The high HABP2 protein expression in 
stroma and vessels in fertile women, and not in epithelial cells, together with increased 
endometrial endothelial cell migration toward HABP2 protein refer to the role of 
HABP2 in the blood coagulation pathway and angiogenesis. In infertile women 
HABP2 endometrial expression pattern was significantly lower. This lower expression 
of HABP2 in infertile women is in line with the tissue factor pathway results, that lower 
level of this coagulation-pathway-initiator may lead to reduced coagulation in infertile 
women. Haemostatic balance may prove to be critical during the formation of new 
blood vessels i.e. angiogenesis that is needed for endometrial maturation and at the time 
of implantation, when the blastocyst interacts with the endometrium and trophoblast 
cells breach endometrial blood vessels, thereby establishing the primordial 
uteroplacental circulation. 
 
It is known that genetic variation within the gene and its regulatory area can influence 
gene expression level. An additional finding in the current thesis demonstrates that 
polymorphisms in the regulatory area of TF, TFPI and HABP2 genes may influence 
mRNA and/or protein expression levels in the endometrium (Figure 19).  
 
 
Figure 19. Illustration of genetic variation in TF, TFPI, HABP2 genes and their 
influence on gene and/or protein expression levels in the endometrium. 
 
 
Women with TF rs1361600 G allele show higher TF immunostaining intensities in 
different cell types, and women carrying TFPI rs10931292 T allele were more 
frequently infertile and had higher TFPI immunostaining in the luminal epithelium. Our 
findings are in agreement with the previous studies, where the TF rs1361600 G allele 
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has been associated with increased plasma TF level (Arnaud, et al., 2000; Reny, et al., 
2004), and the TFPI rs10931292 T allele has been associated with higher TFPI 
expression and is proposed as a genetic protective factor for deep vein thrombosis 
(Amini Nekoo and Iles, 2008). Our findings of HABP2 gene polymorphisms are novel. 
Polymorphisms rs1157916 G/A and rs2240879 A/G in HABP2 gene could serve as 
genetic risk factors for female infertility, the rs1157916 G allele and the rs2240879 G 
allele were more frequent among infertile women, meanwhile these women had lower 
HABP2 mRNA and protein levels than controls. 
Endometrial maturation to the receptive phase is also characterised by structural 
changes. One of these characteristics are endometrial pinopodes, that arise from the 
apical surface of the epithelial cells and cover the endometrial surface at the time of 
embryo implantation (Nikas, 1999). Pinopodes are believed to serve as endometrial 
receptivity morphological markers, although opposing results exist. In the current 
thesis, we detect the co-expression of endometrial receptivity factors and pinopodes. 
The presence of pinopodes significantly correlate with LIFR expression in the luminal 
epithelium, and with TF expression in the glandular epithelium and in stroma in fertile 
endometrium. Additionally we found that pinopodes are more abundant in endometria 
from fertile women than in endometria from women with unexplained infertility, 
referring to the aberrant endometrial maturation in these women.  
 
Figure 20. Illustration of studies of single gene analysis of endometrial receptivity 
factors in fertile women and women with unexplained infertility. 
 
 
 
5.2 FACTORS IMPORTANT FOR IMPLANTATION-COMPETENT 
BLASTOCYST DEVELOPMENT 
 
Formation of the implantation-competent blastocyst is as important as a receptive 
endometrium for successful embryo implantation. Next we analysed the whole gene 
expression pattern of embryos for identifying genes and gene networks activated within 
the blastocyst-stage embryos. Preimplantation development of embryos includes 
critical events such as the transition from maternal to embryonic genome activation, 
compaction, cavitation and blastocyst formation (Bell, et al., 2008). However, given the 
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scarcity of human embryos for research, the molecular mechanisms within the 
developing embryo are not well understood. One important finding in the current thesis 
is that a big proportion of the expressed genes in the blastocyst-stage embryos are 
involved in transcription regulation, and especially transcriptional down-regulation. 
Our finding is the human is well in line with the existence of transcriptional 
programmed waves identified in mice embryos, where maternal to embryonic gene 
activation shows two principal transient waves of de novo transcription, where the first 
wave peaks between the 2- and 4-cell stages and the second wave peaks at the 8-cell 
stage and precedes morula-to-blastocyst formation (Hamatani, et al., 2004).  
 
Another important finding in the current thesis is the identification of one possible 
regulation mechanism for the extensive transcriptional re-programming in the 
developing embryos, namely identification of miRNAs. miRNAs are a class of small 
non-coding RNAs that regulate gene expression at the post-transcriptional level via 
directing either target mRNA degradation or translational repression (Bartel, 2004; 
Bartel, 2009), and they are involved in many biological processes, including 
development, tissue morphogenesis, cell growth, differentiation, apoptosis, metabolism, 
and others (Zhao and Srivastava, 2007). With our study, we are the first to carry out an 
extensive miRNA analysis in human embryos based on an in silico prediction model, 
and we identified several miRNAs in human blastocyst-stage embryos. Additionally, 
our miRNA prediction approach also demonstrates that a considerable proportion of 
miRNA target genes of transcriptional regulators are down-regulated in preimplantation 
embryos. 
 
 
5.3 INTERACTIONS BETWEEN RECEPTIVE ENDOMETRIUM AND 
BLASTOCYST-STAGE EMBRYO 
 
Successful implantation depends on the embryo’s development into an implantation-
competent blastocyst and the synchronised transformation of the uterus into a receptive 
stage. Endometrium secretes molecules that influence embryo development, while the 
presence of an embryo in the uterus triggers specific molecular and cellular responses 
within the uterus (Carson, et al., 2000). The success of the implantation further relies 
upon the two-way dialogue between the blastocyst and the endometrium. In the last 
study of the current thesis we focus on identifying the molecule-molecule interactions 
between the blastocyst and the endometrium at the time of implantation in humans. For 
that we applied, in collaboration with biostatisticians, a novel mathematical modelling 
approach.  
It is ethically impossible to study human implantation in vivo, and most information 
concerning the molecular mechanisms involved in implantation is derived from animal 
models, which cannot fully be extrapolated to humans. One promising alternative is to 
apply computational analysis and integration methods to the knowledge obtained 
separately from human endometrial tissue analysis and from human embryos cultured 
in vitro. Our novel systems-biology analysis of human endometrial tissue and cultured 
embryos reveals several known and new genes and gene networks in the implantation 
process in humans. 
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The main interaction network in our study highlights the importance of cell adhesion 
molecules, including integrins, collagens and laminins in the implantation process. 
Indeed, in the initial stage of implantation the blastocyst interacts with the endometrium 
using adhesion molecules, followed by stable adhesion (Aplin, 1997). Also in focus of 
the first interacting molecules, we found cytokine–cytokine receptor interactions to be 
important, where osteopontin and LIF and LEP pathways intertwine. We also propose 
several new players in human embryo–endometrium interaction, including APOD, 
BGN, EDN1, FBLN2, FGF7, GAST, KREMEN1, NRP1, SERPINA3, VCAN and 
others. 
 
Global gene expression analyses clearly demonstrate the complexity of a tissue 
regulation on molecular level, and that not solely one factor is crucial for implantation 
success in humans. As for instance seen in the case of LIF gene. LIF is one of the most 
important and studied genes related to implantation, and its crucial role in mice 
implantation has been demonstrated (Stewart, et al., 1992). In the current thesis we see 
clearly LIF pathway involvement in human embryo implantation. However, although 
LIF expression is an indicator of receptive endometrium, its role in the assessment of 
implantation potential in humans is controversial (Aghajanova, 2010), and the use of 
recombinant human LIF has failed to improve the outcome of IVF treatment in women 
with recurrent implantation failure (Brinsden, et al., 2009). Although the role of LIF in 
the human implantation process has been proved to be important, it seems not to be 
crucial, but rather a part of a highly coordinated orchestra. The complex implantation 
process is, like other systems of nature, in interrelationships of opposing forces, where 
affecting one factor in this balance, the opposing counterpart has to adjust in parallel for 
avoiding imbalances. This theory of equilibrium (Weghofer and Gleicher, 2009) could 
well explain the countless number of unsolved questions in human implantation process 
– there is not only a single answer since every answer is relative, depending on where 
the balance of any given system lies. 
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6 CONCLUSIONS 
Adequate preparation of receptive endometrium and the establishment and maintenance 
of a viable embryo are prerequisites for successful embryo implantation. Research in 
the field of implantation in humans is actively ongoing, nevertheless the molecular 
bases of these preimplantation and implantation processes are not well known.  
 
The main findings of the current thesis are:  
 
• Identification of new and also previously known genes and pathways involved 
in endometrial preparation for the receptive phase, including JAK-STAT 
signalling pathway, coagulation cascade, focal adhesion, inflammatory 
responses, and others. 
 
• Several genes and pathways that are important for endometrial receptivity are 
dysregulated in women with otherwise no clear reason for their fertility 
problems, including LIF pathway, coagulation pathway (TF pathway, HABP2), 
inflammatory responses, lipid metabolism, and detoxification. 
 
• Abundant presence of pinopodes in fertile mid-secretory endometrium and their 
co-expression with LIFR and TF proteins in endometrial cells; meanwhile 
women with unexplained infertility demonstrate very few pinopodes at the time 
of implantation. 
 
• Polymorphisms in the regulatory area of genes involved in blood coagulation 
pathway (TF, TFPI and HABP2 genes) influence protein expression levels in 
endometrial cells, and the variants of TFPI and HABP2 could serve as potential 
genetic risk factors for unexplained female infertility. 
 
• Implantation-competent embryos demonstrate significant down-regulation of 
genes involved in transcription regulation, where one possible mechanism for 
this transcriptional re-programming could operate via microRNA molecules.  
 
• Identification of new and previously suggested molecules and molecular 
pathways involved in embryo-endometrium dialogue at the time of 
implantation, including adhesion molecules, LIF pathway, gastrin, endothelin, 
versican and many others. 
 
In conclusion, the current thesis gives new insights into the process of embryo 
implantation in humans. With different analysis methods applied, we detect several 
factors that are believed to have role in the preimplantation and implantation processes, 
and we identify several new molecules and molecular pathways in these molecular 
processes. Additionally, we demonstrate that dysregulation of these pathways could 
lead to fertility complications in women with unexplained infertility. Increasing our 
understanding of the genes and pathways involved in the key mechanisms of 
implantation will facilitate the development of strategies to manipulate endometrial 
function, embryo development and embryo-endometrium dialogue in order to promote 
successful implantation and alleviate infertility; or on the contrary, to inhibit fertility. 
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